Fexuclue to Prevent Stomach Ulcers from Pain Relievers
Part of Digestive system clinical trials.
This trial tests whether a medication called Fexuclue can protect your stomach when you take NSAIDs (common pain relievers like ibuprofen or naproxen). If you need to take NSAIDs regularly, this study looks at how well Fexuclue prevents painful stomach ulcers in everyday practice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 19 years old
- You need to take NSAIDs (pain relievers) regularly for your condition
- You need protection against stomach ulcers caused by NSAIDs
- Your doctor prescribes you Fexuclue Tablet 20 mg
- You are not pregnant, breastfeeding, or planning to become pregnant during the study
- You do not have severe liver disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called JP-1366 to see if it can prevent stomach ulcers caused by long-term NSAID use (like ibuprofen or naproxen) for conditions such as arthritis. It may be a good fit if you need to take NSAIDs for at least 24 weeks and have a higher risk of ulcers.
This study tests a new medicine called Ilaprazole 10 mg to see if it can prevent stomach ulcers caused by NSAIDs (pain relievers like ibuprofen). If you take NSAIDs regularly and have a higher risk of ulcers, this trial may help protect your stomach.
This study tests whether a medication called fexuprazan can protect your stomach from ulcers while you take NSAIDs (common pain relievers like ibuprofen) for ongoing joint or muscle problems. The trial checks if it's safe and works better than standard care.
This study watches patients with acute or chronic gastritis who are already being prescribed the stomach medicine Fexuclu (fexuprazan). It collects information to see how well the medicine works and if it causes any side effects in everyday use.
This trial tests whether fexuprazan can prevent upper gastrointestinal bleeding in people at high risk who need two antiplatelet drugs for at least 6 months after a heart stent. If you are on dual antiplatelet therapy after a stent and have risk factors like older age, low weight, or history of ulcers, this study may help protect your stomach.
This trial tests whether fexuprazan can help prevent stomach bleeding in people with atrial fibrillation who take blood thinners like apixaban or rivaroxaban. If you are at higher risk for stomach bleeding, this study may offer extra protection.
Hear when a new Peptic Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.